In a report released on April 11, Salveen Richter from Goldman Sachs maintained a Buy rating on Regeneron (REGN – Research Report), with a ...

GSK's (GSK) stock rises as the company's Arexvy shot could see expanded CDC recommendations for RSV protection in at-risk adults aged 50-59 this week. Read more here.

The S&P 500 gained 0.6% on Monday, March 31, boosted by an afternoon rally even as investors brace for the planned onset of ...

US indices retreat on tariff worries as VIX jumps to 22.44. Nvidia drops 3.9%, Microsoft falls 2.2%, while defensive sectors provide limited market support.

The major U.S. equity indexes were lower midday Monday, as the Trump administration showed no signs of pulling back from ...

In this article, we are going to look at where Moderna, Inc. (NASDAQ ... and a supportive regulatory environment, Goldman Sachs referred to it as an “undervalued opportunity.” ...

US stocks saw choppy trading on Tuesday (April 15) as investors digested a new round of first-quarter earnings reports and ...

S&P 500 and Nasdaq had their worst quarters since 2022 due to concerns over Trump's economic policy and new tariffs. The S&P 500 dropped 4.6% and Nasdaq fell 10.5%. Tech stocks like Tesla and Nvidia ...

The S&P 500 and the Nasdaq Composite today posted their worst quarterly performances since 2022, as uncertainty around the Trump administration’s economic agenda roiled U.S. equity markets in the ...